The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 31, 2021

Filed:

Jun. 19, 2019
Applicants:

Institut National DE LA Recherche Agronomique, Paris, FR;

Museum National D'histoire Naturelle, Paris, FR;

Ecole Nationale Veterinaire D'alfort, Maison Alfort, FR;

Inventors:

Luis G. Bermudez-Humaran, Jouy en Josas, FR;

Thibault Allain, Gentilly, FR;

Isabelle Florent, Paris, FR;

Philippe Langella, Velizy, FR;

Philippe Grellier, Choisy-le-roi, FR;

Marie-Agnes Travers, Marennes, FR;

Bruno Polack, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/50 (2006.01); C12N 9/80 (2006.01); A61K 38/00 (2006.01); A61K 38/16 (2006.01); A61K 38/46 (2006.01); A61K 35/741 (2015.01); A61K 35/744 (2015.01); A23L 33/135 (2016.01); G01D 5/24 (2006.01); H03K 17/955 (2006.01);
U.S. Cl.
CPC ...
A61K 38/50 (2013.01); A23L 33/135 (2016.08); A61K 35/741 (2013.01); A61K 35/744 (2013.01); A61K 38/00 (2013.01); A61K 38/164 (2013.01); A61K 38/46 (2013.01); C12N 9/80 (2013.01); C12Y 305/01024 (2013.01); G01D 5/24 (2013.01); H03K 17/955 (2013.01); A23V 2002/00 (2013.01); A23Y 2220/03 (2013.01); A23Y 2220/37 (2013.01); A23Y 2220/43 (2013.01); H03K 2217/96075 (2013.01); H03K 2217/960745 (2013.01); Y02A 50/30 (2018.01);
Abstract

The present invention relates to a composition exhibiting a bile-salt hydrolase activity for its use for the treatment or the prevention of giardiasis, said composition comprising a bile-salt hydrolase (BSH)enzyme, a bacterium able to secrete a BSH, a recombinant host cell able to secrete a BSH, or a combination thereof. The present invention also relates to the use of a composition exhibiting a BSH activity for the treatment or the prevention of giardiasis, and to a pharmaceutical composition or a food composition comprising, as an active principle, a BSH, a lactic acid bacterium able to secrete a BSH, or a recombinant host cell able to secrete a BSH.


Find Patent Forward Citations

Loading…